Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study

Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States

(2017) J. Michael Woolley et al.   HEADACHE

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

(2017) Stewart Tepper et al.   LANCET NEUROLOGY

Adherence to oral migraine-preventive medications among patients with chronic migraine

(2014) Zsolt Hepp et al.   CEPHALALGIA

Preventive treatment in migraine and the new US guidelines

(2013) Emad Estemalik et al.   Neuropsychiatric Disease and Treatment

Defining the Differences Between Episodic Migraine and Chronic Migraine

(2011) Zaza Katsarava et al.   Current Pain and Headache Reports

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

(2010) SK Aurora et al.   CEPHALALGIA

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

(2010) HC Diener et al.   CEPHALALGIA

The Importance of Placebo in Headache Research

(2008) H-C Diener et al.   CEPHALALGIA